Chinese Property Stocks Fall on Subdued Sentiment Following Weak Sales
By Jiahui Huang
Chinese property stocks fell in Hong Kong on subdued investor sentiment with companies reporting weaker contracted sales for December and the full year of 2023 as the property sector downturn continues.
The Hang Seng Mainland Properties Index, which tracks Chinese property developers, was 3.2% lower at the midday break on Tuesday, taking losses for this week to 4.5%. Longfor declined 7.1% and Yuexiu Property fell 6.6%, while Country Garden Holdings and Country Garden Services were 5.6% and 5.0% lower, respectively. Sunac China, Sino-Ocean Group, Kaisa Group and Greenland Hong Kong were each more than 6.5% lower.
The property stocks weighed on the benchmark Hang Seng Index, which was 1.9% lower at the midday break.
Last week, Seazen Group said its contracted sales fell 35% in 2023 while Guangzhou R&F Properties reported a 48% decline for the year.
Daiwa recently downgraded its rating on Longfor to outperform from buy on concerns that large amounts of low-margin inventory could weigh on its earnings in the short term.
China's property sector has had a weak start in 2024, Nomura analysts said in a recent note. Over the past week, new home sales volume growth weakened sharply on year, especially in tier-2 and low-tier cities, the analysts said.
China's new home sales in 30 major cities have declined 41% year-to-date in 2024, likely reflecting that the challenges may be larger than what the market expects, Gary Ng, senior economist at Natixis said, quoting data provided by Wind.
"Together with the slow restructuring progress and policy support, investors are losing patience for the long-waiting recovery," he said.
Write to Jiahui Huang at jiahui.huang@wsj.com
(END) Dow Jones Newswires
January 16, 2024 00:47 ET (05:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth